TrialJournal of atherosclerosis and thrombosis2024

Efficacy and Safety of Pemafibrate Extended-Release Tablet: a Phase 3, Multicenter, Randomized, Double-Blind, Active-Controlled, Parallel-Group Comparison Trial.

Hidenori Arai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.